​

Applied Therapeutics Ownership | Who Owns Applied Therapeutics?

OverviewForecastRevenueFinancialsChart

Applied Therapeutics Ownership Summary

Applied Therapeutics is owned by 60.62% institutional investors, 5.61% insiders, and 33.78% retail investors. Schonfeld strategic advisors is the largest institutional shareholder, holding 60.70% of APLT shares. T. Rowe Price Small-Cap Value is the top mutual fund, with 8.10% of its assets in Applied Therapeutics shares.

APLT Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockApplied Therapeutics60.62%5.61%33.78%
SectorHealthcare Stocks 486.50%11.08%-397.59%
IndustryBiotech Stocks 304.14%11.08%-215.23%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Schonfeld strategic advisors8.76M60.70%$7.50M
Vanguard group5.55M38.44%$4.75M
Deutsche bank ag\4.47M30.95%$3.84M
Geode capital management2.08M14.44%$1.78M
State street2.07M14.32%$1.77M
Franklin resources2.00M13.88%$1.72M
T. rowe price investment management18.68M12.88%$5.79M
Vestal point capital, lp11.50M7.93%$3.58M
Propel bio management11.29M7.78%$3.51M
Goldman sachs group1.02M7.08%$874.70K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Propel bio management11.29M4.26%$3.51M
Stempoint capital lp2.21M3.03%$10.33M
Knoll capital management7.80M1.72%$2.43M
Vestal point capital, lp11.50M0.19%$3.58M
Artal group1.01M0.12%$4.71M
Birchview capital, lp280.00K0.09%$87.11K
Simplify asset management4.49M0.07%$1.40M
Schonfeld strategic advisors8.76M0.04%$7.50M
Rock springs capital management lp2.08M0.04%$645.84K
Tang capital management2.43M0.04%$755.40K

Top Buyers

HolderShares% AssetsChange
Schonfeld strategic advisors8.76M0.04%8.42M
T. rowe price investment management18.68M0.00%8.30M
Blackrock6.57M0.00%5.58M
Susquehanna group, llp556.00K0.00%522.15K
Morgan stanley3.52M0.00%325.69K

Top Sellers

HolderShares% AssetsChange
Vr adviser---5.57M
Franklin resources2.00M0.00%-4.80M
Blackrock funding, inc. /de5.22M--4.33M
Alyeska investment group---3.11M
Frazier life sciences management---2.29M

New Positions

HolderShares% AssetsChangeValue
Birchview capital, lp280.00K0.09%280.00K$87.11K
Norges bank243.20K-243.20K$208.23K
Ubs asset management americas119.03K-119.03K$101.89K
Roble, belko & company30.84K0.00%30.84K$10.00K
China universal asset management24.67K0.00%24.67K$21.12K

Sold Out

HolderChange
Ifp advisors-1.00
National bank of canada /fi/-4.00
Headlands-23.00
Geowealth management-27.00
Rothschild investment-35.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202576-19.15%87,954,198-17.06%600.97%29-29.27%30-9.09%
Mar 31, 20257-94.62%37,179,368-67.70%270.00%2-97.53%2-92.31%
Dec 31, 2024127-11.19%109,297,179-3.04%7570.12%79-8.14%26-18.75%
Sep 30, 202414341.58%112,721,8809.20%78011.51%8537.10%3337.50%
Jun 30, 20241011.00%103,226,9789.86%821.47%62-7.46%2450.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
T. Rowe Price Small-Cap Value11.47M8.10%-13.42K
T. Rowe Price U.S. SC Value Eq Tr-D6.65M4.70%3.00M
Simplify Propel Opportunities ETF4.49M3.16%-
Vanguard US Total Market Shares ETF3.15M2.71%-
T. Rowe Price U.S. SC Value Eq Tr-Z3.65M2.66%1.76M
Vanguard Total Stock Mkt Idx Inv3.04M2.14%-66.40K
SPDR® S&P Biotech ETF1.74M1.49%24.74K
Janus Henderson Global Life Sciences D1.62M1.39%1.30M
Janus Henderson Glb Life Scn I2 USD1.29M1.11%1.29M
Franklin Biotechnology Discv A(acc)USD1.26M0.89%-

Recent Insider Transactions

DateNameRoleActivityValue
Mar 04, 2025Perfetti Riccardo Chief Medical OfficerSell$4.56K
Mar 04, 2025Funtleyder Leslie D. See RemarksSell$6.38K
Mar 04, 2025Chinoporos Constantine See RemarksSell$196.68
Feb 06, 2025Funtleyder Leslie D. See RemarksSell$14.00K
Feb 06, 2025Perfetti Riccardo Chief Medical OfficerSell$52.51K

Insider Transactions Trends

DateBuySell
2025 Q3--
2025 Q2--
2025 Q1-6
2024 Q4--
2024 Q3-5

APLT Ownership FAQ

Who Owns Applied Therapeutics?

Applied Therapeutics shareholders are primarily institutional investors at 60.62%, followed by 5.61% insiders and 33.77% retail investors. The average institutional ownership in Applied Therapeutics's industry, Biotech Stocks , is 304.14%, which Applied Therapeutics falls below.

Who owns the most shares of Applied Therapeutics?

Applied Therapeutics’s largest shareholders are Schonfeld strategic advisors (8.76M shares, 60.70%), Vanguard group (5.55M shares, 38.44%), and Deutsche bank ag\ (4.47M shares, 30.95%). Together, they hold 130.09% of Applied Therapeutics’s total shares outstanding.

Does Blackrock own Applied Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Applied Therapeutics.

Who is Applied Therapeutics’s biggest shareholder by percentage of total assets invested?

Propel bio management is Applied Therapeutics’s biggest shareholder by percentage of total assets invested, with 4.26% of its assets in 11.29M Applied Therapeutics shares, valued at 3.51M$.

Who is the top mutual fund holder of Applied Therapeutics shares?

T. Rowe Price Small-Cap Value is the top mutual fund holder of Applied Therapeutics shares, with 8.10% of its total shares outstanding invested in 11.47M Applied Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools